Mobile
Get a Free Consultation
What Is Stage 4 Prostate Cancer
Blog

What Is Stage 4 Prostate Cancer & Prognosis

What is stage 4 prostate cancer prognosis?” begins a critical inquiry into the outlook for patients diagnosed with this advanced form of prostate cancer. Stage 4 prostate cancer means the cancer has spread beyond the prostate gland to distant organs or lymph nodes. The prognosis for stage 4 prostate cancer can vary widely among individuals, depending on factors such as the extent of the spread, the patient’s overall health, and how well the cancer responds to treatment.

What is stage 4 prostate cancer prognosis?” also prompts an exploration of the statistical outcomes associated with this late-stage diagnosis. Survival rates, while helpful for understanding the general outlook, do not predict individual outcomes. According to the American Cancer Society, the 5-year relative survival rate for men with distant spread of prostate cancer (stage 4) is about 31%. However, many men live much longer than five years after diagnosis, especially if the cancer responds well to treatment.

What Is Stage 4 Prostate Cancer?  

What is stage 4 prostate cancer prognosis?” begins a critical inquiry into the outlook for patients diagnosed with this advanced form of prostate cancer. Stage 4 prostate cancer means the cancer has spread beyond the prostate gland to distant organs or lymph nodes. The prognosis for stage 4 prostate cancer can vary widely among individuals, depending on factors such as the extent of the spread, the patient’s overall health, and how well the cancer responds to treatment.

What is stage 4 prostate cancer prognosis?” also prompts an exploration of the statistical outcomes associated with this late-stage diagnosis. Survival rates, while helpful for understanding the general outlook, do not predict individual outcomes. According to the American Cancer Society, the 5-year relative survival rate for men with distant spread of prostate cancer (stage 4) is about 31%. However, many men live much longer than five years after diagnosis, especially if the cancer responds well to treatment.

What Are the Physical Symptoms of Stage 4 Prostate Cancer? 

Signs and symptoms of stage 4 prostate cancer may include:

  • Painful urination
  • Decreased force in the stream of urine
  • Blood in the semen
  • Bone pain
  • Swelling in the legs
  • Fatigue

In addition to managing these symptoms, cancer treatment plays a crucial role in controlling the progression of stage 4 prostate cancer and improving the patient’s quality of life. Treatments for prostate cancer at this advanced stage often focus on slowing the spread of the cancer and alleviating symptoms. Hormone therapy, which reduces the body’s production of testosterone, a hormone that prostate cancer cells rely on to grow, remains a cornerstone of treatment.

Medications that target the prostate-specific antigen (PSA) can help monitor the effectiveness of treatment and the progression of the disease. When cancer has spread to other parts of the body, such as the bones, treatments may include radiation therapy to relieve pain or targeted therapy that focuses on specific aspects of cancer cells to inhibit their growth. Furthermore, clinical trials offer access to new and experimental therapies that might be effective against advanced prostate cancer. Participating in clinical trials can provide patients with cutting-edge treatments that are not yet widely available and contribute to the advancement of cancer care.

What Is the Survival Rate of Stage 4 Prostate Cancer?  

Doctors use the term stage to characterize the characteristics of the original tumor itself, such as its size and how far prostate cancer has spread when it is discovered, as they do with all malignancies.

Staging systems are difficult to understand. Most malignancies, including prostate cancer, are staged using three different elements of tumor growth and dissemination. The TNM system stands for tumor, nodes, and metastasis:

  • T, for tumor (which means a swelling, a growth or mass, and describes the cancer as found in its place of origin) describes the size of the main area of prostate cancer.  
  • N, for nodes, describes whether prostate cancer has spread to any lymph nodes, and how many and in what locations. 
  • M, for metastasis, means distant spread of prostate cancer, for example, to the bones or liver. 

The TNM approach allows each man’s prostate cancer to be characterized in depth and compared to the prostate cancers of other men. Doctors utilize this information to conduct research and make treatment decisions.

However, in terms of prostate cancer survival statistics, the staging method is straightforward. As previously stated, males with prostate cancer can be split into two groups in terms of survival rates:

  • Men with prostate cancer that is localized to the prostate or just nearby. 
  • Prostate cancer has a high long-term survival percentage in these men. Almost all men will live for more than five years after being diagnosed with prostate cancer, and many will live for much longer.
  • Men whose prostate cancer has spread to distant areas, like their bones.
  • These individuals may require more aggressive cancer of prostate treatment. Only roughly one-third of these men will live for more than five years after being diagnosed with prostate cancer.

What Is the Life Expectancy for Stage 4 Prostate Cancer? 

Prostate cancer life expectancy is determined using five-year survival rates. This is the percentage of people who may still be alive five years after being diagnosed.

The five-year survival rate for men with localized prostate cancer, where there is no evidence of cancer spreading outside the prostate, and regional prostate cancer, when cancer has migrated outside the prostate to adjacent structures or lymph nodes exclusively, is approximately 100 percent.

When prostate cancer reaches stage 4 and has spread (metastasized) to other organs such as the lungs, liver, or bones, the five-year survival rate falls below 30%. At stage 4, prostate cancer is unlikely to be cured, although with effective therapy, many people can live for several years. The patient’s life expectancy is determined by the precise characteristics of his cancer.

However, thanks to routine screening procedures, prostate cancer is often discovered early, before it has spread to other organs, and it is usually not fatal. When diagnosed early, there are several treatment options available, as well as a good likelihood of a cure.


The range of treatment options available for prostate cancer varies significantly depending on the stage at which the cancer is diagnosed and the specific parts of the body to which it has spread. For men with localized or regional prostate cancer, radical prostatectomy, a surgical procedure to remove the prostate gland and some of the tissue around it, can often be curative. This approach, along with radiation therapy and hormone therapy, forms the cornerstone of cancer treatment for those with cancer confined to the prostate or nearby areas.

Stage 4 Prostate Cancer Prognosis   

Doctors need to know how far the cancer has advanced, or its stage, in order to choose the best treatment. A pathologist, a specialist who specializes in studying cells obtained from a prostate biopsy, will provide two starting points: the cancer’s grade and Gleason score.

  • Cancer grade: When the pathologist looks at prostate cancer cells, the most common type of cells will get a grade of 3 to 5. The area of cancer cells in the prostate will also be graded. The higher the grade, the more abnormal the cells.
  • Gleason score: The two grades will be added together to get a Gleason score. This score tells doctors how likely the cancer is to grow and spread.

After a biopsy reveals prostate cancer, the patient may be subjected to additional testing to determine whether the disease has spread to other regions of the body via the blood or lymph nodes. These are typically imaging examinations, such as a bone scan, positron emission tomography (PET) scan, or computed tomography (CT) scan.
Understanding the prostate cancer survival rate is crucial for patients and their families to grasp the seriousness of the diagnosis and to foster realistic expectations regarding the treatments for prostate cancer. The prostate specific antigen (PSA) level is a vital marker used not only in screening and diagnosing prostate cancer but also in monitoring the effectiveness of treatment. When prostate cancer has spread to other parts of the body, the treatment strategy shifts from curative to palliative, with the goal of extending quality life and managing symptoms.

Clinical trials play a pivotal role in the development of new treatments, offering hope for improved survival rates and potentially more effective management of prostate cancer. Participation in clinical trials can provide access to the latest treatments and contribute to the advancement of medical knowledge in the fight against this disease.

Stage 4 Prostate Cancer Clinical Trials   

Clinical trials provide cancer patients with life-extending and curative new medicines. Clinical drug trials are critical in getting new medicines to patients who need them the most, as well as securing data so that regulatory clearances may be secured, and new drugs can enter broad clinical practice. Patients who take part in clinical trials benefit both treatment science and their fellow patients.

There are currently 100 Phase III drug trials and more than 500 Phase I/II trials related to prostate cancer treatment in progress in the United States alone. Those that are approved will join the 12 new drugs that have been approved for men with advanced/metastatic disease since 2010 and further improve outcomes for patients:

Using our AI-powered approach, Massive Bio leads patients through the most extensive clinical trial matching process available.

We can assist you if you have been diagnosed with any of the following prostate cancer subtypes:

  • Adenocarcinoma
  • Transitional Cell Carcinoma
  • Small Cell Carcinoma

If you do not know which type of prostate cancer you have, that is okay. Additional testing can help you determine your exact diagnosis.

14 Comments

  • I’ve been recently diagnosed with stage 4 prostate cancer that has spread to lympnotes. I am presently getting radiation treatments at University of New Mexico.

    My radiation treatments end on August 10th 2022. I have been scheduled for another Pet/Bone Scan on July 22, 2022 at 7:30 AM followed by my 20 minutes radiation treatment at 11:AM on the same day.

    Is it safe to have the above two mentioned on the same day?

    • Cancer Treatment Expert says:

      Hi Eddie. A PET scan will not affect your radiation treatment. However, if you have further concerns, you may always speak to your doctor or the nurse assigned to you during your appointment regarding these concerns and they would be happy to address it before you get started.

  • Patsy says:

    My husband was diagnosed with stage 4, Gleason score 9, prostate cancer which had metastasized to lymph nodes when he was 59 years old. He received 9 weeks of radiation and 3 years of hormone injections. He is now 69 years old and doing just fine. Does this mean he has beat cancer?

    • Cancer Treatment Expert says:

      Hi Patsy,

      First of all, I am very glad that your wife is doing well. For information on the subject, you can call our number +1 844 627 7246.

  • Olagboju solomon says:

    My elder brother was diagnosed with prostate cancer stage 4, Gleason 8 which had spread to the bone in the month of March 2020,, he did orchiectomy in June, same year because there was no hormone injection in that Hospital. He has been taking different supplement after the operation. Now he’s having bone pains in the waist, arm and tight, what should we do to save his life. I’m a Nigerian , living in a small village in the North Central.

  • Brian Roberts says:

    Originally diagnosed with Prostate in 2007. Treatment with Hormones and radiation. Slowly my PSA rose from 0.08 to between 9.5 and 10. Then it started to climb very eradically to 17. at that time I had a ct scan which showed involvement in pelvic lymph nodes and a bone scan which showed no metastasis. I am presently on zoladex every 12 weeks and apalutamide 240mg daily. My PSA has dropped 17 to 0.17 in 4 months. will this effect the prognosis. Also my PSA was eradic after taking the covid vaccines. Is there any link.

  • Monishaa Prabhakar says:

    Hi, my dad is been diagnosed with Stage 4B prostrate cancer with a Gleason score of 8 (4+4). It’s adenocarcinoma with metasis. The cancer has spread to lymph nodes and a small nodule in his right lung with PCMA agents in shoulder lesions and vertebrae v1.
    What would be the prognosis for him to increase his life expectancy? He is 59 now and have diabetes. Else he is fit.

  • Unknown says:

    My in-law recently diagnosed with T4N1 prostrate cancer having 84 year old age.What to do now as having old age he will not tolerate any treatment or surgery.

    • Cancer Treatment Expert says:

      Hello, sorry to hear about your in-laws diagnosis, we always recommend consulting the patients local physicians for treatment recommendations, hoping for the best outcome.

  • K Rajesh says:

    My father was diagnosed with 4b postrate cancer and he admitted in hospital PSA value was 52 and he had 35 radiotherapy sittings in last 4 months. After that the PSA value came down to 12, so docter has given 3 chimotherapy sittings in 1 month. Again PSA rised to 53 and cancer spread to right humerous, both scapula, 2 left side ribs. Docters told ur that his life span is maximum 1 year.. they are going to start radiotherapy now.. is there any chance to survive at this condition.

    • Cancer Treatment Expert says:

      Hello, so sorry to hear of your father’s diagnosis, there are a few factors which can contribute to a patients health and the outcome of treatments, inlcuding their current diagnosis, age, physical condition and medical history. We are hoping for the best outcome for him.

Leave a Reply

Your email address will not be published. Required fields are marked *

Join our community
and receive our newsletter